PMAC 2016 Side Event (SE 014): Advanced Workshop in Methods for HTAThe methods of HTA have developed rapidly in the last decade. This is particularly the case in assessing the cost-effectiveness of interventions using modelling methods and in undertaking uncertainty analysis to guide decisions. Deci

PMAC 2016 Side Event (SE 013): Introduction to Health Intervention and Technology Assessment: HITA 101“Health Intervention and Technology Assessment (HITA) is recognized as a tool in support of universal health coverage (UHC) to inform policy decision. It becomes an increasingly important part of pr

PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces

During the PMAC 2015, a side meeting on the role of the international Decision Support Initiative (http://www.idsihealth.org/about-us/) was organized in order to discuss: progress of the initiative so far and the challenges of country-led reforms. To begin, NICE International gave a presentation on

More dentists need to be checking their patients for mouth cancer, say experts.Cancer Research UK says oral cancer rates are going up and some dentists are missing an opportunity to spot those at risk.All dentists should be asking about risk factors like smoking or heavy drinking as well as early te

As a Coordinator at the International Unit of the Health Intervention and Technology Assessment Program (HITAP), Piyaphat supports regional and global initiatives that strengthen health systems through evidence-informed policymaking. With a background in liberal arts and professional experience across the humanitarian, public, and private sectors,

A new oral medication to treat patients in the early stages of multiple sclerosis has shown considerable promise in two clinical trials, researchers announced on Wednesday.The medication is on track to become just the third oral drug available to M.S. patients, and potentially the safest and most ef

Picharee Karunayawong is a researcher and economist at the Health Intervention and Technology Assessment Program Foundation (HITAP). Her work focuses on data-driven and quantitative research aimed at improving the efficiency of national health systems and reducing the use of low-value care. She works closely with the policymakers, participating in

HTAsiaLink 20188-11 May 2018, Chiang Mai, ThailandMore than 200 participants from over 30  HTA organizations and other academic and policy making agencies across the global joined this conference!The themes of this years’ conference is Testing Treatments: Strengthening HTA for better healthcare.For

Phornnaphat is a licensed pharmacist with a diverse academic background, holding a bachelor\'s degree in pharmacy from Silpakorn University and a master’s degree in molecular biology from Nagoya University (MEXT Scholarship). With this interdisciplinary training, she specializes in applying data and evidence to inform health policy.Her research foc